Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Otomize ear spray
120101050BCAAAB
|
Otomize | Dexamethasone | Ear, Nose and Oropharynx | 377,957 |
|
Maxidex 0.1% eye drops
1104010I0BBAAAD
|
Maxidex | Dexamethasone | Eye | 28,575 |
|
Dexamethasone 0.1% eye drops
1104010I0AAADAD
|
Dexamethasone (Eye) | Dexamethasone | Eye | 27,968 |
|
Dexamethasone 2mg tablets
0603020G0AAADAD
|
Dexamethasone (Systemic) | Dexamethasone | Endocrine System | 25,867 |
|
Dexamethasone 500microgram tablets
0603020G0AAABAB
|
Dexamethasone (Systemic) | Dexamethasone | Endocrine System | 17,677 |
|
Dexamethasone 0.1% eye dps 0.4ml unit dose preservative free
1104010I0AAATAT
|
Dexamethasone (Eye) | Dexamethasone | Eye | 13,032 |
|
Maxitrol eye drops
1104010I0BCAAAE
|
Maxitrol | Dexamethasone | Eye | 11,605 |
|
Dexamethasone 0.1% eye drops preservative free
1104010I0AAAUAU
|
Dexamethasone (Eye) | Dexamethasone | Eye | 10,884 |
|
Dexafree 1mg/1ml eye drops 0.4ml unit dose
1104010I0BHAAAT
|
Dexafree | Dexamethasone | Eye | 10,241 |
|
Dexamethasone 2mg/5ml oral solution sugar free
0603020G0AABXBX
|
Dexamethasone (Systemic) | Dexamethasone | Endocrine System | 9,925 |
|
Maxitrol eye ointment
1104010I0BCABAF
|
Maxitrol | Dexamethasone | Eye | 8,371 |
|
Dexamethasone 2mg soluble tablets sugar free
0603020G0AACFCF
|
Dexamethasone (Systemic) | Dexamethasone | Endocrine System | 5,472 |
|
Dexamethasone 0.1% eye dps 0.5ml unit dose preservative free
1104010I0AAALAL
|
Dexamethasone (Eye) | Dexamethasone | Eye | 4,254 |
|
Tobradex 3mg/ml / 1mg/ml eye drops
1104010I0BFAAAP
|
Tobradex | Dexamethasone | Eye | 2,950 |
|
Minims dexamethasone 0.1% eye drops 0.5ml unit dose
1104010I0BEAAAL
|
Minims dexamethasone | Dexamethasone | Eye | 2,515 |
|
Dropodex 0.1% eye drops 0.4ml unit dose
1104010I0BGAAAT
|
Dropodex | Dexamethasone | Eye | 2,444 |
|
Dexamethasone 0.1% / Tobramycin 0.3% eye drops
1104010I0AAAPAP
|
Dexamethasone (Eye) | Dexamethasone | Eye | 1,670 |
|
Dexamethasone 4mg tablets
0603020G0AACICI
|
Dexamethasone (Systemic) | Dexamethasone | Endocrine System | 1,419 |
|
Dexamethasone 0.1% eye dps 0.3ml unit dose preservative free
1104010I0AAAVAV
|
Dexamethasone (Eye) | Dexamethasone | Eye | 1,031 |
|
Eythalm 1mg/ml eye drops
1104010I0BIAAAU
|
Eythalm | Dexamethasone | Eye | 775 |
|
Dexamethasone 4mg soluble tablets sugar free
0603020G0AACHCH
|
Dexamethasone (Systemic) | Dexamethasone | Endocrine System | 611 |
|
Dexamethasone 10mg/5ml oral solution sugar free
0603020G0AABZBZ
|
Dexamethasone (Systemic) | Dexamethasone | Endocrine System | 353 |
|
Dexamethasone 1mg tablets
0603020G0AACNCN
|
Dexamethasone (Systemic) | Dexamethasone | Endocrine System | 266 |
|
Dexamethasone 8mg soluble tablets sugar free
0603020G0AACGCG
|
Dexamethasone (Systemic) | Dexamethasone | Endocrine System | 140 |
|
Puradex 1mg/ml eye drops
1104010I0BKAAAU
|
Puradex | Dexamethasone | Eye | 102 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.